Cleveland Biolabs Inc. Reports First Quarter 2017 Financial Results And Development Progress Post author:Sam Post published:May 15, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Filing Reveals Kendall Square's InVivo Therapeutics is Burning Through Cash Fast January 28, 2018 Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity July 31, 2017 Elite Pharma Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information June 14, 2017
Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity July 31, 2017
Elite Pharma Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information June 14, 2017